| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.0084 | 0.9 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.0084 | 0.9 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.9 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | 0.031 | 0.9 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.9 |